NASDAQ
NEOG
Last Price
US $9.67
KEY FIGURES
MKT CAP
$2.1B
EPS
TTM
$-2.80
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
2.42x
YIELD
0.00%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
-29%
Return on equity
ROIC: -1.15%
Valuation History
-3.4X
Price to Earnings
EV/EBITDA: -6.1X
Cash flow
Profit margin
16.43%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $9.67
—
Default assumptions
EBITDA Multiple
Fair Value
Market $9.67
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Neogen Corporation cash flow to debt ratio of 6.38% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Neogen Corporation's free cash flow has increased -39.14% from $-76.16M last year to $-46.35M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Neogen Corporation's debt to equity ratio is 0.38, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Neogen Corporation's debt has increased relative to shareholder equity from 0.29 last year to 0.38 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Neogen Corporation has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Neogen Corporation's interest coverage ratio is -0.61, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial risk - Profit margin growth.
Neogen Corporation's profit margin has decreased (6.76K%) in the last year from -1.02% to -69.93%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Neogen Corporation's short-term assets of $576.94M exceed its short-term liabilities of $174.01M
Decreasing performance - ROA.
Neogen Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Neogen Corporation's return on equity of -29.00%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Neogen Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Neogen Corporation had positive net income in only 2.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Neogen Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Neogen Corporation has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Neogen Corporation's yearly earnings has decreased 11.49K% since last year from $-9.42M to $-1.09G, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Neogen Corporation's yearly revenue has decreased -3.20% since last year from $924.22M to $894.66M, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -1.15% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Neogen Corporation's 3-year revenue CAGR of 19.28% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Neogen Corporation had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Neogen Corporation had positive ROE in only 2.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Neogen Corporation has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Neogen Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Neogen Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Neogen Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Neogen Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Neogen Corporation has a price-to-book ratio of 1.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Neogen Corporation has a price-to-sales ratio of 2.42x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue